Works by Kim, Byung Soo


Results: 333
    1
    2
    3
    4
    5

    BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.

    Published in:
    Human Mutation, 2004, v. 24, n. 4, p. 350, doi. 10.1002/humu.9275
    By:
    • Seo, Jae Hong;
    • Cho, Dae-Yeon;
    • Ahn, Se-Hyun;
    • Yoon, Kyung-Sik;
    • Kang, Chang-Soo;
    • Cho, Hyun Mi;
    • Lee, Hyeon Sook;
    • Choe, Jae Jin;
    • Choi, Cheul Won;
    • Kim, Byung Soo;
    • Shin, Sang Won;
    • Kim, Yeul Hong;
    • Kim, Jun Suk;
    • Son, Gil-Soo;
    • Lee, Jae-Bok;
    • Koo, Bum Hwan
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial

    Published in:
    American Journal of Cardiovascular Drugs, 2016, v. 16, n. 2, p. 129, doi. 10.1007/s40256-015-0156-x
    By:
    • Sohn, Il;
    • Kim, Chong-Jin;
    • Oh, Byung-Hee;
    • Hong, Taek-Jong;
    • Park, Chang-Gyu;
    • Kim, Byung-Soo;
    • Chung, Woo-Baek
    Publication type:
    Article
    12

    Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial

    Published in:
    American Journal of Cardiovascular Drugs, 2016, v. 16, n. 2, p. 139, doi. 10.1007/s40256-016-0167-2
    By:
    • Sohn, Il;
    • Kim, Chong-Jin;
    • Oh, Byung-Hee;
    • Hong, Taek-Jong;
    • Park, Chang-Gyu;
    • Kim, Byung-Soo;
    • Chung, Woo-Baek
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Hypocalcemia-a complication of childhood leukemia.

    Published in:
    Cancer (0008543X), 1972, v. 29, n. 2, p. 392, doi. 10.1002/1097-0142(197202)29:2<392::AID-CNCR2820290220>3.0.CO;2-A
    By:
    • Jaffe, Norman;
    • Kim, Byung Soo;
    • Vawter, Gordon F.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
    By:
    • Ki-Seong Eom;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Cheolwon Suh;
    • Jin Seok Kim;
    • Sung-Soo Yoon;
    • Byung Soo Kim;
    • Hye Jin Kang;
    • Young Jin Choi;
    • Chul Soo Kim;
    • Yang Soo Kim;
    • Jae-Yong Kwak;
    • Yoo Jin Kim;
    • Young Don Joo;
    • Yeung-Chul Mun;
    • Deog Yeon Jo;
    • Joon Seong Park;
    • Chi-Young Park;
    • Sung-Hyun Kim;
    • Chang-Ki Min
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Biomaterials for tissue engineering.

    Published in:
    World Journal of Urology, 2000, v. 18, n. 1, p. 2, doi. 10.1007/s003450050002
    By:
    • Byung-Soo Kim;
    • Baez, Carlos E.;
    • Atala, Anthony
    Publication type:
    Article
    48
    49
    50